The inside story behind the pandemic, the CEO and a promising, unproven treatment.
Cowen Healthcare Investments has raised a $493 million fund, breezing past its original goal by close to $100 million. The fund closure positions Cowen to continue following an investment ...
Money from the largest biotech IPO in history, funding from an international outbreak preparedness group and an award from the U.S. government are apparently still not enough for Moderna. ...
A San Francisco startup is targeting low-grade gliomas, planning to make precision treatments as available for kids with cancer as they are for adults.
Scientists reveal potential COVID-19 therapy using structural biology to further understand SARS-CoV-2 neutralizing antibodies.
Johannes Fruehauf, co-founder of LabCentral, interviews four biotech startup executives about their coronavirus response.
The remote work movement is accelerating, with Facebook, Twitter, Square, and Shopify signaling a permanent shift. What does that mean for Silicon Valley?